These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 220462)

  • 21. [Clinical picture and treatment of insulin resistance in primary hyperlipoproteinaemia (author's transl)].
    Vogelberg KH; Gries FA; Dietel J
    Dtsch Med Wochenschr; 1973 Sep; 98(38):1751-8. PubMed ID: 4355086
    [No Abstract]   [Full Text] [Related]  

  • 22. Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusion.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):49-51. PubMed ID: 395089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peri-operative management of insulin-dependent diabetic patients. Use of continuous intravenous infusion of insulin-glucose-potassium solution.
    Bowen DJ; Nancekievill ML; Proctor EA; Norman J
    Anaesthesia; 1982 Aug; 37(8):852-5. PubMed ID: 7051887
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
    Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C
    Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incidence of hyperlipoproteinaemia in patients with chemical and clinical diabetes (author's transl)].
    Reimer F; Kremer GJ; Müller D
    Klin Wochenschr; 1973 Oct; 51(19):973-8. PubMed ID: 4762586
    [No Abstract]   [Full Text] [Related]  

  • 26. Programming of an open-loop system for i.v. insulin infusion in insulin-dependent diabetes.
    Mirouze J; Selam JL; Pham TC; Chenon D
    Acta Diabetol Lat; 1980; 17(2):103-9. PubMed ID: 7004038
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction.
    Gwilt DJ; Petri M; Lamb P; Nattrass M; Pentecost BL
    Br Heart J; 1984 Jun; 51(6):626-30. PubMed ID: 6375702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peroperative insulin treatment].
    Scherpereel P
    Ann Fr Anesth Reanim; 1985; 4(1):59-65. PubMed ID: 3885798
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood lipid/variations in the diabetic. I. Preventive note].
    Sassu G; Simonetti M
    Clin Ter; 1976 Feb; 76(3):261-4. PubMed ID: 183931
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of diabetes mellitus using continuous subcutaneous infusion].
    van Ballegooie E; Sluiter WJ; Reitsma WD; Doorenbos H
    Ned Tijdschr Geneeskd; 1980 Nov; 124(48):2038-42. PubMed ID: 7003403
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus.
    Sönksen PH; Srivastava MC; Tompkins CV; Nabarro JD
    Lancet; 1972 Jul; 2(7769):155-9. PubMed ID: 4114062
    [No Abstract]   [Full Text] [Related]  

  • 32. [Subcutaneous infusion of insulin in diabetics: clinical results].
    Pickup JC; Keen H; White MC; Kohner EM; Parsons JA; Alberti KG
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():17-22. PubMed ID: 6995668
    [No Abstract]   [Full Text] [Related]  

  • 33. [Etiology and clinical significance of hypertriglyceridemia in diabetes mellitus].
    Shmushkovich BI
    Ter Arkh; 1971 Jul; 43(6):8-12. PubMed ID: 4942294
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of insulin-dependent diabetes by continuous subcutaneous infusion of insulin (author's transl)].
    Buysschaert M; Lejeune M; Lambert AE
    Ann Endocrinol (Paris); 1981; 42(3):293-4. PubMed ID: 7316465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)].
    Zöller H; Gross W
    MMW Munch Med Wochenschr; 1976 Apr; 118(16):493-4. PubMed ID: 178994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion.
    Pietri A; Dunn FL; Raskin P
    Diabetes; 1980 Dec; 29(12):1001-5. PubMed ID: 7002668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein B levels and altered lipoprotein composition in diabetes.
    Schonfeld G; Birge C; Miller JP; Kessler G; Santiago J
    Diabetes; 1974 Oct; 23(10):827-34. PubMed ID: 4371149
    [No Abstract]   [Full Text] [Related]  

  • 38. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical application of open-loop systems for blood glucose control (author's transl)].
    Granić M; Topić E; Stavljenić A; Skrabalo Z
    Lijec Vjesn; 1980 Nov; 102(11):657-60. PubMed ID: 7024695
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clofibrate in the treatment of diabetes mellitus].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):359-62. PubMed ID: 30153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.